[go: up one dir, main page]

AR065903A1 - Derivados nuevos de 2,3- benzodiazepina y su uso como agentes antipsicoticos - Google Patents

Derivados nuevos de 2,3- benzodiazepina y su uso como agentes antipsicoticos

Info

Publication number
AR065903A1
AR065903A1 ARP080101355A ARP080101355A AR065903A1 AR 065903 A1 AR065903 A1 AR 065903A1 AR P080101355 A ARP080101355 A AR P080101355A AR P080101355 A ARP080101355 A AR P080101355A AR 065903 A1 AR065903 A1 AR 065903A1
Authority
AR
Argentina
Prior art keywords
alkyl
group
phenyl
independently
compound
Prior art date
Application number
ARP080101355A
Other languages
English (en)
Inventor
Emese Csuzdi
Katalin Horvath
Sandor Solyom
Pal Berzsenyi
Istvan Sziraki
Zoltan Nagy
Ferenc Andrasi
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of AR065903A1 publication Critical patent/AR065903A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/02—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Reivindicacion 1: Un compuesto de la formula (1) caracterizado porque R1 es metilo y R2 es hidrogeno; R3 es a) un anillo heterocíclico de 5 o 6 miembros que es aromático, saturado o parcialmente saturado, dicho anillo heterocíclico contiene 1, 2, o3 heteroátomos seleccionados del grupo formado por O, S, o N, dicho anillo heterocíclico opcionalmente sustituido por un grupo alquilo C1-3, alquenilo C2-3 o un grupo oxo; o b) un compuesto de formula (2) caracterizado porque X es O o S; R11 eshidrogeno, alquilo C1-4 o cicloalquilo o fenilo, y R12 es alquilo C1-4, cicloalquilo, fenilo, o alcoxi C1-3, o R11 y R12 juntos con el átomo de nitrogeno al cual están unidos forman un grupo imidazolio o morfolinilo, o c) un compuesto de formula (3)caracterizado porque R13 es alquilo C1-4 o fenilo; R4, R5, R6, R7 y R8 son cada una independientemente H, halogeno, alquilo C1-3, nitro, NR15R16 caracterizado porque R15 y R16 pueden independientemente ser H, alquilo C1-3, acil C2-5, alcoxicarboniloC2-5, aminocarbonilo, o alquiloaminocarbonilo C1-5; y R9 y R10 son cada uno independientemente alcoxi C1-3; o un estereoisomero o una sal farmacéuticamente aceptable del mismo.
ARP080101355A 2007-04-02 2008-04-01 Derivados nuevos de 2,3- benzodiazepina y su uso como agentes antipsicoticos AR065903A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92153207P 2007-04-02 2007-04-02
US93663107P 2007-06-20 2007-06-20

Publications (1)

Publication Number Publication Date
AR065903A1 true AR065903A1 (es) 2009-07-08

Family

ID=39598447

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080101355A AR065903A1 (es) 2007-04-02 2008-04-01 Derivados nuevos de 2,3- benzodiazepina y su uso como agentes antipsicoticos

Country Status (7)

Country Link
US (1) US20080269202A1 (es)
AR (1) AR065903A1 (es)
CL (1) CL2008000949A1 (es)
IL (1) IL201126A0 (es)
PE (1) PE20090801A1 (es)
TW (1) TW200902024A (es)
WO (1) WO2008124075A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6333251B2 (ja) * 2012-08-16 2018-05-30 バイエル ファーマ アクチエンゲゼルシャフト ２，３−ベンゾジアゼピン類
MA38346B1 (fr) 2013-02-19 2019-05-31 Bayer Pharma AG 2,3-benzodiazépines bicyclo- et spirocyclosubstituées
EP3010909A1 (de) * 2013-06-17 2016-04-27 Bayer Pharma Aktiengesellschaft Substituierte phenyl-2,3-benzodiazepine
WO2015121230A1 (de) * 2014-02-14 2015-08-20 Bayer Pharma Aktiengesellschaft 9-substituierte 2,3-benzodiazepine
CN118161504B (zh) * 2024-05-11 2024-07-19 首都医科大学宣武医院 Ro 5-3335在抗衰老中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU186760B (en) * 1981-03-12 1985-09-30 Gyogyszerkutato Intezet Process for preparing 3,4-dihydro-5h-2,3-aenzodiazepine derivatives
HU191698B (en) * 1984-07-27 1987-03-30 Gyogyszerkutato Intezet Process for producing new 1-aryl-5h-2beta-benzodiazepines
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
DK1157992T3 (da) * 1994-08-31 2005-10-24 Lilly Co Eli Dihydro-2,3-benzodiazepinederivativer
DE19604920A1 (de) * 1996-02-01 1997-08-07 Schering Ag Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
US6887867B2 (en) * 2000-06-16 2005-05-03 Transgenomic, Inc. 5H-2,3-benzodiazepine antagonists of excitatory amino acid receptors
US6858605B2 (en) * 2003-02-04 2005-02-22 Ivax Drug Research Institute, Ltd. Substituted 2,3-benzodiazepine derivatives

Also Published As

Publication number Publication date
CL2008000949A1 (es) 2008-10-03
PE20090801A1 (es) 2009-07-29
US20080269202A1 (en) 2008-10-30
IL201126A0 (en) 2010-05-17
TW200902024A (en) 2009-01-16
WO2008124075A1 (en) 2008-10-16

Similar Documents

Publication Publication Date Title
CO6321244A2 (es) Pirrolopiridinas como inhibidores de cinasa
PE20140207A1 (es) Composiciones y metodos para modular el fxr
AR054799A1 (es) Derivados de oxindol
PE20091952A1 (es) Compuestos de tiazole y oxazole de sulfonamida de benzeno
PE20070189A1 (es) COMPUESTO DE AMINO-5-HETEROARILO (5 MIEMBROS) IMIDAZOLONA Y SU USO PARA MODULACION DE LA ß-SECRETASA
AR056536A1 (es) Compuestos de 2-amino-5- [4-(difluormetoxi)fenil]-5-fenilimidazolona como inhibidores de la beta secretasa (bace)
AR067757A1 (es) Derivados de imidazo[4,5-c]piridin-2-ona, composiciones farmaceuticas que los contienen, procedimiento para su preparacion y uso de los mismos como agentes antivirales.
PE20090276A1 (es) Compuestos derivados de imidazoquinolina como moduladores de tlr7
PE20141308A1 (es) Nuevos compuestos inhibidores de la fosfodiesterasa tipo 10a
ES2630079T3 (es) Moduladores de la ruta del complemento y usos de los mismos
AR082153A1 (es) N-sulfonilbenzamidas utiles como inhibidor del canal de sodio
AR071386A1 (es) Compuestos heterociclicos nitrogenados, inhibidores carbamato y urea de la 11-beta-hidroxiesteroide deshidrogenasa tipo 1(11 beta-hsd1),composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de la obesidad,hipertension,trastornos cognitivos y otras enfermedades.
PE20091818A1 (es) DERIVADOS POLISUSTITUIDOS DE 2-ARIL-6-FENIL-IMIDAZO[1,2-a] PIRIDINAS, SU PREPARACION Y SU APLICACION EN TERAPEUTICA
AR078793A1 (es) Derivados de carboxamidas no esteroidales y acil hidrazona moduladores de receptores androgenicos de tejido selectivo (sarm), composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del cancer de prostata entre otros
ES2530943T3 (es) Derivados de la cromenona con actividad antitumoral
AR054081A1 (es) Derivados de pirimidina, procesos de obtencion y composiciones farmaceuticas
AR073688A1 (es) Agonistas de receptores cb2, derivados de oxazoles y/o triazoles, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del dolor, enfermedades autoinmunes y alergicas, entre otras.
CO5611147A2 (es) Derivados de nicotinamida utiles como inhibidores p38
PE20120561A1 (es) Compuestos que modulan selectivamente el receptor cb2
AR067478A1 (es) Compuestos derivados de morfolina pirimidina
PE20140863A1 (es) Compuestos de benceno sustituidos con arilo o heteroarilo
AR068846A1 (es) Compuestos derivados de pirrolo (2,3d)-pirimidina inhibidores de la actividad de pkb, composiciones farmaceuticas que los contienen, proceso de preparacion y uso de los mismos como agentes anticancer
AR085615A1 (es) Derivados de fluoropiridinona utiles como agentes antibacterianos y composiciones farmaceuticas que los contienen
PE20070212A1 (es) Heterociclos de 1,4-dihidropiridina-condensados, procesos para preparar los mismos, uso y composiciones que los contienen
AR080467A1 (es) Derivados tetrazolicos moduladores selectivos de receptores cb2, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del dolor y otras enfermedades

Legal Events

Date Code Title Description
FB Suspension of granting procedure